Transoral Robotic Surgery Feasible for Oropharyngeal SCC

This article originally appeared here.
Share this content:
Transoral Robotic Surgery Feasible for Oropharyngeal SCC
Transoral Robotic Surgery Feasible for Oropharyngeal SCC

TUESDAY, Oct. 27, 2015 (HealthDay News) -- For patients with oropharyngeal squamous cell carcinoma (SCC), transoral robotic surgery is feasible, according to a study published in the November issue of Head & Neck.

Balazs B. Lörincz, M.D., from the University Medical Centre Hamburg-Eppendorf in Germany, and colleagues conducted a single-institution prospective study to examine the feasibility, completeness of resection, and functional outcomes for oropharyngeal SCC treated with transoral robotic surgery. Participants included 35 patients with T1 and T2 oropharyngeal SCC who underwent transoral robotic surgery between September 2011 and April 2013. Patients were followed for a median of 13 months.

For the preliminary oncology outcome, the researchers assessed completeness of resection, disease-free survival, and cancer recurrence. The results were encouraging, with clear resection margins achieved in 33 patients. In 37.1 percent of cases (13 patients), adjuvant treatment was completely spared. At the last follow-up (median, 13 months), 30 patients (85.7 percent) were recurrence-free, and 34 patients were alive. In functional outcomes, the median duration of nasogastric tube feeding was five days and none of the patients had a nasogastric tube at the last follow-up. Patients spent a median of one day in the intensive care unit and a median of one day intubated. Patients had to be taken back to the operating theater because of postoperative bleeding from the resection site on two occasions.

"Based upon our early oncologic and functional outcomes, we are convinced that further clinical investigations are justified and continued efforts to decrease the overall treatment-related morbidity of the multimodality therapy of head and neck SCC are encouraged," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »